[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Insider transaction summary for CLOROX CO (CLX)

On 10/03/2025 Director and Chief Executive Officer Linda J. Rendle received 43,370 shares of common stock following settlement of a 2022 performance unit grant that vested on 10/03/2025. The shares were issued at an effective price of $122.25 per share. The filing shows share withholding to satisfy tax obligations: 1,022 shares withheld for performance stock unit taxes and 8,440 shares withheld for restricted stock taxes. After these transactions and including 4,274 dividend-reinvested shares, the reporting person beneficially owned 201,990 shares (direct).

Positive

• Settlement of performance units converted deferred compensation to equity: 43,370 shares added
• Dividend reinvestment contributed 4,274 shares to long-term ownership

Negative

• Tax-related withholding reduced net new shares by 9,462
• No sale reported—but withholding lowered the immediate incremental ownership from the grant

Insights

Compensation Governance Analyst

CEO received vested performance units; standard tax withholding reduced net shares.

The settlement of a 2022 performance unit grant converted to 43,370 shares on 10/03/2025, increasing direct ownership before withholding. The reporting person elected to defer settlement under the 2005 Stock Incentive Plan, consistent with common executive compensation practice.

Tax-withholding removed 9,462 shares in total (1,022 + 8,440), lowering net new shares added. Monitor future Form 4s for any elective sales or additional deferral elections within the next 12 months.

Equity Ownership Analyst

Beneficial ownership remains material at just over 201,000 shares after vesting and withholding.

Following settlement and withholding, the filing reports 201,990 shares beneficially owned directly. The filing also notes 4,274 shares from a dividend reinvestment feature, which modestly increases long-term stake without immediate cash outlay.

Investors tracking insider alignment should note the combination of deferred settlement and dividend reinvestment as signals of retained ownership; any future open-market sales would be disclosed on subsequent Form 4 filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rendle Linda J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/03/2025		A(1)		43,370	A	$122.25	211,452	D
Common Stock	10/03/2025		F(2)		1,022	D	$122.25	210,430	D
Common Stock	10/03/2025		F(3)		8,440	D	$122.25	201,990(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Settlement of 2022 Performance Unit Grant that vested 10/3/25, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.

2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.

3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.

4. Includes 4,274 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

	By Angela Hilt, Attorney-in-Fact for	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did CLX CEO Linda Rendle report on Form 4?

The CEO reported settlement of a 2022 performance unit grant on 10/03/2025, receiving 43,370 shares at $122.25 per share, with 1,022 and 8,440 shares withheld for tax purposes.

How many CLX shares does Linda Rendle beneficially own after the transaction?

The filing reports 201,990 shares beneficially owned directly following the reported transactions.

Why were some shares withheld in the CLX Form 4 filing?

The company withheld shares to satisfy tax obligations related to vesting of performance stock units and restricted stock, totaling 9,462 shares withheld.

Did the filing show any open-market sales of CLX stock by the reporting person?

No open-market sales were reported; the Form 4 shows acquisition via settlement and withholding for taxes, not sales.

Was there any dividend-related change disclosed in the CLX Form 4?

Yes, 4,274 shares were acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.